Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.6.1.1 (
aspartate aminotransferase
)
21,665
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The effect of continuous removal of thoracic duct lymph on plasma activities of creatine phosphokinase (PCK),
glutamic-oxaloacetic transaminase
(
PAST
); and lactic dehydrogenase (PLDH), uas examined in pentobarbital-anaesthetised dogs over a 5.5-hour period. PCK and
PAST
declined relative to levels in control dogs while PLDH was unaltered. Lymph/plasma (L/P) ratios for
AST
and CPK were greater, and for LDH less, than the L/P ratio for total protein. It was concluded that PCK, and to some extent
PAST
, are normally maintained by introduction of enzyme, escaping from the intracellular compartment, into the circulating blood via the lymphatic system. PLDH and
PAST
appear to be maintained principally by introduction of enzyme directly from the intracellular to the plasma compartment.
...
PMID:Plasma enzyme levels in the anaesthetised dog during drainage of thoracic duct lymph. 124 97
